Andres Μ. Salazar

23.9k total citations · 5 hit papers
171 papers, 10.8k citations indexed

About

Andres Μ. Salazar is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Andres Μ. Salazar has authored 171 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Immunology, 52 papers in Epidemiology and 40 papers in Molecular Biology. Recurrent topics in Andres Μ. Salazar's work include Immunotherapy and Immune Responses (57 papers), Traumatic Brain Injury Research (33 papers) and Traumatic Brain Injury and Neurovascular Disturbances (25 papers). Andres Μ. Salazar is often cited by papers focused on Immunotherapy and Immune Responses (57 papers), Traumatic Brain Injury Research (33 papers) and Traumatic Brain Injury and Neurovascular Disturbances (25 papers). Andres Μ. Salazar collaborates with scholars based in United States, Germany and Switzerland. Andres Μ. Salazar's co-authors include Jordan Grafman, Karen Schwab, Deborah L. Warden, D. Carleton Gajdusek, Ralph M. Steinman, Dina Amin, Christine Trumpfheller, Rodney D. Vanderploeg, Glenn Curtiss and H R Brown and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Andres Μ. Salazar

168 papers receiving 10.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

2014 567 citations Andres Μ. Salazar et al. profile →
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

2009 536 citations Andres Μ. Salazar et al. profile →
Frontal lobe injuries, violence, and aggression

1996 513 citations Karen Schwab, Andres Μ. Salazar et al. profile →
Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status

1991 479 citations Melvyn P. Heyes, Bruce J. Brew et al. Annals of Neurology profile →
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination

2019 321 citations Thomas U. Marron, Andres Μ. Salazar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andres Μ. Salazar United States	57	4.4k	2.5k	2.0k	1.9k	1.5k	171	10.8k
Andrew R. Lloyd Australia	72	4.2k 0.9×	5.2k 2.0×	1.9k 0.9×	2.4k 1.3×	942 0.6×	457	19.5k
Wallace W. Tourtellotte United States	51	3.0k 0.7×	1.3k 0.5×	2.9k 1.4×	1.8k 0.9×	4.1k 2.7×	155	16.3k
Carlos A. Pardo United States	56	1.1k 0.3×	1.4k 0.5×	4.0k 2.0×	638 0.3×	3.2k 2.1×	192	15.0k
Howard S. Fox United States	60	2.2k 0.5×	2.0k 0.8×	3.5k 1.8×	709 0.4×	542 0.4×	269	11.4k
Carol K. Petito United States	52	1.1k 0.2×	2.4k 0.9×	2.0k 1.0×	728 0.4×	1.6k 1.0×	143	10.8k
Steven D. Douglas United States	63	5.1k 1.2×	2.2k 0.9×	3.1k 1.6×	1.0k 0.5×	219 0.1×	463	15.5k
Marc Tardieu France	49	1.1k 0.3×	1.2k 0.5×	1.3k 0.7×	593 0.3×	2.8k 1.8×	179	8.5k
Clayton A. Wiley United States	57	1.9k 0.4×	2.7k 1.1×	2.5k 1.2×	811 0.4×	729 0.5×	232	11.7k
Paul S. Foster Australia	78	10.3k 2.3×	2.2k 0.9×	3.9k 1.9×	1.1k 0.6×	380 0.2×	354	23.2k
Susan Morgello United States	66	1.1k 0.2×	2.4k 0.9×	2.1k 1.0×	953 0.5×	1.3k 0.8×	275	13.3k

Countries citing papers authored by Andres Μ. Salazar

Since Specialization

Citations

This map shows the geographic impact of Andres Μ. Salazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andres Μ. Salazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andres Μ. Salazar more than expected).

Fields of papers citing papers by Andres Μ. Salazar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andres Μ. Salazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andres Μ. Salazar. The network helps show where Andres Μ. Salazar may publish in the future.

Co-authorship network of co-authors of Andres Μ. Salazar

This figure shows the co-authorship network connecting the top 25 collaborators of Andres Μ. Salazar. A scholar is included among the top collaborators of Andres Μ. Salazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andres Μ. Salazar. Andres Μ. Salazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salazar, Andres Μ., et al.. (2023). Hiltonol, a dsRNA Mimic, Promotes NK Cell Anticancer Cytotoxicity Through TAZ Cytoplasmic Sequestration. Advanced Therapeutics. 6(8). 2 indexed citations

Chang, Shu‐Chun, Emily Chia‐Yu Su, Tsung‐Han Hsieh, et al.. (2021). Hiltonol Cocktail Kills Lung Cancer Cells by Activating Cancer-Suppressors, PKR/OAS, and Restraining the Tumor Microenvironment. International Journal of Molecular Sciences. 22(4). 1626–1626. 14 indexed citations

Pavlick, Anna C., Ana-Belén Blázquez, Marcia Meseck, et al.. (2019). Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma. Cancer Immunology Research. 8(1). 70–80. 56 indexed citations

Seyedmousavi, Seyedmojtaba, Michael J. Davis, Janyce A. Sugui, et al.. (2018). Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung. mBio. 9(2). 14 indexed citations

Kyi, Chrisann, Vladimir Roudko, Rachel Lubong Sabado, et al.. (2018). Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial. Clinical Cancer Research. 24(20). 4937–4948. 97 indexed citations

Nabi, Ghulam, William J. McKinstry, Keith K. Khoo, et al.. (2018). Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines. Journal of Virology. 92(14). 29 indexed citations

Sastry, Mallika, Baoshan Zhang, Man Chen, et al.. (2017). Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus. PLoS ONE. 12(10). e0186854–e0186854. 39 indexed citations

Kumaki, Yohichi, Andres Μ. Salazar, Miles K. Wandersee, & Dale L. Barnard. (2016). Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model. Antiviral Research. 139. 1–12. 42 indexed citations

Derouazi, Madiha, Wilma Di Berardino-Besson, Elodie Belnoue, et al.. (2015). Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell–Mediated Antitumor Immunity. Cancer Research. 75(15). 3020–3031. 50 indexed citations

10.

Okada, Hideho, Lisa H. Butterfield, Ronald L. Hamilton, et al.. (2014). Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC. Clinical Cancer Research. 21(2). 286–294. 83 indexed citations

11.

Lévy, Yves, Sandra Zurawski, Anne-Laure Flamar, et al.. (2014). Vaccines for Therapeutic Cellular Immunity that Target HIV Gag, Pol and Nef Epitopes to CD40 and DCIR Elicit T-cell Responses in Rhesus Macaques. AIDS Research and Human Retroviruses. 30(S1). A245–A245. 1 indexed citations

12.

Tsuji, Takemasa, Paul Sabbatini, Achim A. Jungbluth, et al.. (2013). Effect of Montanide and Poly-ICLC Adjuvant on Human Self/Tumor Antigen-Specific CD4+ T Cells in Phase I Overlapping Long Peptide Vaccine Trial. Cancer Immunology Research. 1(5). 340–350. 52 indexed citations

13.

Kimura, Takashi, John McKolanis, Kazi Islam, et al.. (2012). MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study. Cancer Prevention Research. 6(1). 18–26. 186 indexed citations

14.

Murphy, Katherine A., Melissa G. Lechner, Flavia E. Popescu, et al.. (2012). An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas. Clinical Cancer Research. 18(17). 4657–4668. 29 indexed citations

15.

Dias, Camila, Mauro Pires Moraes, Marcelo Weiss, et al.. (2012). Novel Antiviral Therapeutics to Control Foot-and-Mouth Disease. Journal of Interferon & Cytokine Research. 32(10). 462–473. 35 indexed citations

16.

Bogunovic, Dusan, Olivier Manches, Emmanuelle Godefroy, et al.. (2011). TLR4 Engagement during TLR3-Induced Proinflammatory Signaling in Dendritic Cells Promotes IL-10–Mediated Suppression of Antitumor Immunity. Cancer Research. 71(16). 5467–5476. 42 indexed citations

17.

Groswasser, Zeev, Irith Reider‐Groswasser, Karen Schwab, et al.. (2002). Quantitative imaging in late TBI. Part II: cognition and work after closed and penetrating head injury: a report of the Vietnam head injury study. Brain Injury. 16(8). 681–690. 27 indexed citations

18.

Vogelgesang, Scott A., Melvyn P. Heyes, Sterling G. West, et al.. (1996). Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations.. PubMed. 23(5). 850–5. 32 indexed citations

19.

Brenneman, Douglas E., et al.. (1992). Potent gp120-like neurotoxic activity in the cerebrospinal fluid of HIV-infected individuals is blocked by peptide T. Brain Research. 598(1-2). 10–18. 39 indexed citations

20.

Heyes, Melvyn P., Bruce J. Brew, Alex Martin, et al.. (1991). Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status. Annals of Neurology. 29(2). 202–209. 479 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact